DexCom Net Debt from 2010 to 2026

DXCM Stock

USD 69.89 0.93 1.31%

DexCom Net Debt yearly trend continues to be very stable with very little volatility. Net Debt is likely to grow to about 2.4 B this year. Net Debt is the total debt of DexCom Inc minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2005-03-31

Previous Quarter

1.4 B

Current Value

685.3 M

Quarterly Volatility

687.9 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Interest Hikes

Check DexCom financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DexCom's main balance sheet or income statement drivers, such as Interest Expense of 12.2 M, Other Operating Expenses of 4.1 B or Operating Income of 724.5 M, as well as many indicators such as Price To Sales Ratio of 8.52, Dividend Yield of 0.0 or PTB Ratio of 10.1. DexCom financial statements analysis is a perfect complement when working with DexCom Valuation or Volatility modules.

Build AI portfolio with DexCom Stock

Check out the analysis of DexCom Correlation against competitors.

Evaluating DexCom's Net Debt across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into DexCom Inc's fundamental strength.

Latest DexCom's Net Debt Growth Pattern

Below is the plot of the Net Debt of DexCom Inc over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. DexCom's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DexCom's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

DexCom Net Debt Regression Statistics

	Arithmetic Mean	734,683,397
	Coefficient Of Variation	131.17
	Mean Deviation	843,180,114
	Median	(1,100,000)
	Standard Deviation	963,718,864
	Sample Variance	928754T
	Range	2.5B
	R-Value	0.90
	Mean Square Error	182482.8T
	R-Squared	0.82
	Slope	172,374,017
	Total Sum of Squares	14860064.8T

DexCom Net Debt History

	2026	2.4 B
	2025	2.3 B
	2024	2 B
	2023	2 B
	2022	1.5 B
	2021	1.1 B
	2020	1 B

Other Fundumenentals of DexCom Inc

Net Debt To E B I T D A

DexCom Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Retained Earnings	Accounts Payable	Total Liab	Common Stock	Property Plant Equipment	Short Term Investments	Long Term Debt	Net Receivables	Short Term Debt	Current Deferred Revenue	Net Tangible Assets	Total Permanent Equity	Good Will	Capital Surpluse	Treasury Stock	Intangible Assets	Long Term Debt Total	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.98	1.0	0.88	0.98	1.0	0.93	0.99	0.98	0.88	0.98	0.78	0.65	0.99	0.8	0.84	0.87	-0.92	0.87	0.82	0.96	0.81	0.96	0.77	0.8
Total Stockholder Equity	0.99		0.95	0.99	0.82	0.94	0.97	0.91	0.97	0.99	0.9	0.94	0.72	0.6	1.0	0.81	0.87	0.91	-0.93	0.85	0.87	0.93	0.74	0.97	0.82	0.76
Net Debt	0.98	0.95		0.96	0.93	0.95	0.98	0.92	0.98	0.97	0.83	0.98	0.8	0.69	0.95	0.7	0.75	0.8	-0.89	0.88	0.73	0.92	0.83	0.93	0.71	0.84
Total Current Assets	1.0	0.99	0.96		0.84	0.96	0.99	0.9	0.97	0.98	0.91	0.96	0.73	0.63	0.99	0.83	0.87	0.9	-0.93	0.85	0.87	0.97	0.77	0.96	0.82	0.77
Retained Earnings	0.88	0.82	0.93	0.84		0.9	0.91	0.88	0.9	0.83	0.62	0.94	0.89	0.65	0.83	0.51	0.54	0.6	-0.75	0.82	0.5	0.8	0.91	0.81	0.46	0.85
Accounts Payable	0.98	0.94	0.95	0.96	0.9		0.98	0.91	0.96	0.92	0.8	0.98	0.85	0.61	0.94	0.82	0.8	0.81	-0.86	0.86	0.74	0.96	0.89	0.9	0.65	0.81
Total Liab	1.0	0.97	0.98	0.99	0.91	0.98		0.93	0.98	0.97	0.86	0.99	0.8	0.66	0.97	0.78	0.81	0.85	-0.91	0.88	0.79	0.96	0.84	0.95	0.74	0.82
Common Stock	0.93	0.91	0.92	0.9	0.88	0.91	0.93		0.97	0.87	0.75	0.94	0.78	0.63	0.92	0.66	0.76	0.77	-0.89	0.89	0.66	0.84	0.77	0.89	0.64	0.83
Property Plant Equipment	0.99	0.97	0.98	0.97	0.9	0.96	0.98	0.97		0.96	0.83	0.98	0.8	0.69	0.97	0.75	0.82	0.84	-0.92	0.92	0.76	0.92	0.79	0.95	0.72	0.85
Short Term Investments	0.98	0.99	0.97	0.98	0.83	0.92	0.97	0.87	0.96		0.91	0.94	0.69	0.63	0.98	0.78	0.83	0.88	-0.91	0.83	0.86	0.93	0.73	0.96	0.83	0.76
Long Term Debt	0.88	0.9	0.83	0.91	0.62	0.8	0.86	0.75	0.83	0.91		0.81	0.4	0.66	0.9	0.81	0.89	0.9	-0.88	0.71	0.92	0.89	0.51	0.89	0.95	0.61
Net Receivables	0.98	0.94	0.98	0.96	0.94	0.98	0.99	0.94	0.98	0.94	0.81		0.84	0.69	0.94	0.74	0.77	0.79	-0.87	0.9	0.71	0.94	0.88	0.92	0.65	0.86
Short Term Debt	0.78	0.72	0.8	0.73	0.89	0.85	0.8	0.78	0.8	0.69	0.4	0.84		0.39	0.71	0.52	0.46	0.5	-0.62	0.75	0.4	0.72	0.94	0.67	0.23	0.76
Current Deferred Revenue	0.65	0.6	0.69	0.63	0.65	0.61	0.66	0.63	0.69	0.63	0.66	0.69	0.39		0.61	0.44	0.57	0.58	-0.65	0.8	0.45	0.61	0.41	0.69	0.48	0.84
Net Tangible Assets	0.99	1.0	0.95	0.99	0.83	0.94	0.97	0.92	0.97	0.98	0.9	0.94	0.71	0.61		0.8	0.87	0.9	-0.93	0.84	0.87	0.93	0.73	0.97	0.83	0.75
Total Permanent Equity	0.8	0.81	0.7	0.83	0.51	0.82	0.78	0.66	0.75	0.78	0.81	0.74	0.52	0.44	0.8		0.9	0.85	-0.76	0.64	0.83	0.87	0.57	0.75	0.71	0.52
Good Will	0.84	0.87	0.75	0.87	0.54	0.8	0.81	0.76	0.82	0.83	0.89	0.77	0.46	0.57	0.87	0.9		0.98	-0.88	0.72	0.93	0.85	0.49	0.89	0.8	0.65
Capital Surpluse	0.87	0.91	0.8	0.9	0.6	0.81	0.85	0.77	0.84	0.88	0.9	0.79	0.5	0.58	0.9	0.85	0.98		-0.9	0.71	0.96	0.86	0.52	0.94	0.83	0.68
Treasury Stock	-0.92	-0.93	-0.89	-0.93	-0.75	-0.86	-0.91	-0.89	-0.92	-0.91	-0.88	-0.87	-0.62	-0.65	-0.93	-0.76	-0.88	-0.9		-0.84	-0.85	-0.89	-0.63	-0.94	-0.8	-0.76
Intangible Assets	0.87	0.85	0.88	0.85	0.82	0.86	0.88	0.89	0.92	0.83	0.71	0.9	0.75	0.8	0.84	0.64	0.72	0.71	-0.84		0.6	0.8	0.67	0.84	0.55	0.93
Long Term Debt Total	0.82	0.87	0.73	0.87	0.5	0.74	0.79	0.66	0.76	0.86	0.92	0.71	0.4	0.45	0.87	0.83	0.93	0.96	-0.85	0.6		0.84	0.45	0.88	0.9	0.51
Short Long Term Debt	0.96	0.93	0.92	0.97	0.8	0.96	0.96	0.84	0.92	0.93	0.89	0.94	0.72	0.61	0.93	0.87	0.85	0.86	-0.89	0.8	0.84		0.81	0.9	0.75	0.74
Long Term Investments	0.81	0.74	0.83	0.77	0.91	0.89	0.84	0.77	0.79	0.73	0.51	0.88	0.94	0.41	0.73	0.57	0.49	0.52	-0.63	0.67	0.45	0.81		0.69	0.32	0.71
Net Invested Capital	0.96	0.97	0.93	0.96	0.81	0.9	0.95	0.89	0.95	0.96	0.89	0.92	0.67	0.69	0.97	0.75	0.89	0.94	-0.94	0.84	0.88	0.9	0.69		0.8	0.82
Net Working Capital	0.77	0.82	0.71	0.82	0.46	0.65	0.74	0.64	0.72	0.83	0.95	0.65	0.23	0.48	0.83	0.71	0.8	0.83	-0.8	0.55	0.9	0.75	0.32	0.8		0.39
Capital Stock	0.8	0.76	0.84	0.77	0.85	0.81	0.82	0.83	0.85	0.76	0.61	0.86	0.76	0.84	0.75	0.52	0.65	0.68	-0.76	0.93	0.51	0.74	0.71	0.82	0.39

Click cells to compare fundamentals

About DexCom Financial Statements

DexCom investors utilize fundamental indicators, such as Net Debt, to predict how DexCom Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	2.3 B	2.4 B
Net Debt To EBITDA	1.89	1.38

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether DexCom Inc is a strong investment it is important to analyze DexCom's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact DexCom's future performance. For an informed investment choice regarding DexCom Stock, refer to the following important reports:

How To Invest In DexCom

Details

Is DexCom Stock a good investment?

Details

What is DexCom's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of DexCom Correlation against competitors.

You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Will Health Care Equipment & Supplies sector continue expanding? Could DexCom diversify its offerings? Factors like these will boost the valuation of DexCom. Projected growth potential of DexCom fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DexCom data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

1.099

Earnings Share

1.8

Revenue Per Share

11.544

Quarterly Revenue Growth

0.216

Return On Assets

0.0702

Understanding DexCom Inc requires distinguishing between market price and book value, where the latter reflects DexCom's accounting equity. The concept of intrinsic value - what DexCom's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push DexCom's price substantially above or below its fundamental value.

It's important to distinguish between DexCom's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DexCom should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, DexCom's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

DexCom Net Debt from 2010 to 2026

Latest DexCom's Net Debt Growth Pattern

DexCom Net Debt Regression Statistics

DexCom Net Debt History

Other Fundumenentals of DexCom Inc

DexCom Net Debt component correlations

About DexCom Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY